Cite

HARVARD Citation

    Cammà, C. et al. (n.d.). Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma1. Hepatology. 57 (3), pp. 1046-1054. [Online]. 
  
Back to record